These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 12709046)

  • 1. Economics of prophylactic treatment.
    Schramm W; Berger K
    Haemophilia; 2003 May; 9 Suppl 1():111-5; dicussion 116. PubMed ID: 12709046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing outcomes of different treatment regimens for severe haemophilia.
    van den Berg HM; Fischer K; van der Bom JG
    Haemophilia; 2003 May; 9 Suppl 1():27-31; discussion 31. PubMed ID: 12709034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Setting research priorities to improve cost-effectiveness estimations of primary prophylaxis with clotting factor for people with severe haemophilia.
    Miners AH; Lee CA
    Haemophilia; 2004 Mar; 10 Suppl 1():58-62. PubMed ID: 14987250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A global view on prophylaxis: possibilities and consequences.
    Shapiro AD
    Haemophilia; 2003 May; 9 Suppl 1():10-7; discussion 18. PubMed ID: 12709032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic factor replacement in hemophilia.
    Carcao MD; Aledort L
    Blood Rev; 2004 Jun; 18(2):101-13. PubMed ID: 15010149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. When should prophylactic treatment in patients with haemophilia A and B start?--The German experience.
    Kreuz W; Escuriola-Ettingshausen C; Funk M; Schmidt H; Kornhuber B
    Haemophilia; 1998 Jul; 4(4):413-7. PubMed ID: 9873763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemophilia Burden of Disease: A Systematic Review of the Cost-Utility Literature for Hemophilia.
    Thorat T; Neumann PJ; Chambers JD
    J Manag Care Spec Pharm; 2018 Jul; 24(7):632-642. PubMed ID: 29952709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is haemophilia prophylaxis achievable in the context of self-sufficiency?
    Nilsson IM
    Blood Coagul Fibrinolysis; 1994 Dec; 5 Suppl 4():S71-5. PubMed ID: 7795143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness in establishing hemophilia carrier detection and prenatal diagnosis services in a developing country with limited health resources.
    Sasanakul W; Chuansumrit A; Ajjimakorn S; Krasaesub S; Sirachainan N; Chotsupakarn S; Kadegasem P; Rurgkhum S
    Southeast Asian J Trop Med Public Health; 2003 Dec; 34(4):891-8. PubMed ID: 15115107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost effectiveness of haemophilia treatment: a cross-national assessment.
    Lippert B; Berger K; Berntorp E; Giangrande P; van den Berg M; Schramm W; Siebert U;
    Blood Coagul Fibrinolysis; 2005 Oct; 16(7):477-85. PubMed ID: 16175006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is Continuous Low-Dose Prophylaxis Superior to On-Demand Treatment for Patients with Hemophilia?
    Windyga J
    Semin Thromb Hemost; 2016 Jul; 42(5):533-40. PubMed ID: 27096764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective controlled studies on prophylaxis: an Italian approach.
    Gringeri A
    Haemophilia; 2003 May; 9 Suppl 1():38-42; discussion 43. PubMed ID: 12709036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemophilia B: impact on patients and economic burden of disease.
    Gater A; Thomson TA; Strandberg-Larsen M
    Thromb Haemost; 2011 Sep; 106(3):398-404. PubMed ID: 21833450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modern Treatments of Haemophilia: Review of Cost-Effectiveness Analyses and Future Directions.
    Cortesi PA; D'Angiolella LS; Lafranconi A; Micale M; Cesana G; Mantovani LG
    Pharmacoeconomics; 2018 Mar; 36(3):263-284. PubMed ID: 29170896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health economics in haemophilia: a review from the clinician's perspective.
    Escobar MA
    Haemophilia; 2010 May; 16 Suppl 3():29-34. PubMed ID: 20586799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consumption of clotting factors in severe haemophilia patients undergoing prophylaxis and on-demand treatment in Italy.
    Giampaolo A; Abbonizio F; Puopolo M; Arcieri R; Mannucci PM; ; Hassan HJ; Accorsi A; Ettorre PC; Schiavoni M; Palareti G; Rodorigo G; Valdré L; Amaddii G; Billio A; Notarangelo L; Iannacaro P; Muleo P; Biasioli C; Rossi V; Alatri A; Testa S; Vincenzi D; Scapoli G; Morfini M; Molinari AC; Lapecorella M; Mariani G; Baudo F; Caimi MT; Federici AB; Gringeri A; Mannucci PM; Santagostino E; Marietta M; Coppola A; Di Minno G; Perricone C; Schiavulli M; Miraglia E; Rocino A; Zanon E; Gagliano F; Mancuso G; Siragusa S; Rivolta F; Tagliaferri A; Gamba G; Iorio A; Oliovecchio E; Dragani A; Arbasi MC; Albertini P; Mancino A; Lombardo VT; Latella C; D'Incà M; Landolfi Raffaele ; Biondo Francesca ; Mazzucconi MG; Santoro Cristina ; Mameli AL; Piseddu G; Schinco PC; Messina M; Rossetti G; Barillari G; Feola G; Franchini M; Gandini G; Castaman G; Rodeghiero F
    Transfus Med; 2011 Aug; 21(4):280-4. PubMed ID: 21733006
    [No Abstract]   [Full Text] [Related]  

  • 17. Cost-utility analysis of primary prophylaxis versus treatment on-demand for individuals with severe haemophilia.
    Miners AH; Sabin CA; Tolley KH; Lee CA
    Pharmacoeconomics; 2002; 20(11):759-74. PubMed ID: 12201795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost of care of haemophilia with inhibitors.
    Di Minno MN; Di Minno G; Di Capua M; Cerbone AM; Coppola A
    Haemophilia; 2010 Jan; 16(1):e190-201. PubMed ID: 19845772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemophilia A: pharmacoeconomic review of prophylaxis treatment versus on-demand.
    Unim B; Veneziano MA; Boccia A; Ricciardi W; La Torre G
    ScientificWorldJournal; 2015; 2015():596164. PubMed ID: 25685844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic evaluation of major knee surgery with recombinant activated factor VII in hemophilia patients with high titer inhibitors and advanced knee arthropathy: exploratory results via literature-based modeling.
    Ballal RD; Botteman MF; Foley I; Stephens JM; Wilke CT; Joshi AV
    Curr Med Res Opin; 2008 Mar; 24(3):753-68. PubMed ID: 18234151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.